We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Epicept v. Minister of Health; interlocutory motion for confidentiality; histamine
  • Gowling WLG
  • Canada
  • February 12 2010

Epicept has filed for a judicial review of the Minister's decision that its histamine dihydrochloride product is not an innovative drug and is thus not eligible for listing on the register of innovative drugs


Pfizer v. ratiopharm, motion to amended a previous judgment on the merits
  • Gowling WLG
  • Canada
  • December 3 2009

ratiopharm was successful in the proceeding under the NOC Regulations at the trial level, but the decision was overturned on appeal


Janssen-Ortho v. Novopharm; merits of 55.2 proceeding; methylphenidate
  • Gowling WLG
  • Canada
  • February 12 2010

The only issue in this proceeding was an allegation of non-infringement and the application for prohibition was dismissed


Bayer Inc. v. Canada (Health), listing decision
  • Gowling WLG
  • Canada
  • December 3 2009

The Court dismissed a judicial review of the Minister’s decision refusing to list a formulation patent on the Patent Register


Pfizer v. ratiopharm, motion to intervene in appeal of infringement proceedings
  • Gowling WLG
  • Canada
  • December 3 2009

The Court of Appeal denied BIOTEC Canada’s and Eli Lilly’s leave to intervene in Pfizer’s appeal of the Court’s decision to invalidate a patent for amlodipine


Mycogen v. Bayer and Monsanto; motion for summary judgment
  • Gowling WLG
  • Canada
  • February 12 2010

Bayer brought a motion for summary judgment on the basis that Monsanto had missed the time set out by the Commissioner under section 43 of the Patent Act to respond to the conflict proceeding


Recent cases
  • Gowling WLG
  • Canada
  • August 21 2009

The Court granted an order of prohibition to Purdue in the face of Pharmascience’s allegations that the patent was invalid


Bayer v. Canada
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register


Apotex v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • May 28 2009

Apotex brought a judicial review of the Minister’s refusal to issue a NOC regarding its version of aspirin


Lundbeck v. Ratiopharm and Cobalt
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review